Rank | Gene Set | Z-score |
---|---|---|
1 | response to peptidoglycan (GO:0032494) | 4.79625619 |
2 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.41337589 |
3 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.32945525 |
4 | negative regulation of interleukin-12 production (GO:0032695) | 4.10576042 |
5 | regulation of mast cell degranulation (GO:0043304) | 4.05000289 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 3.90270770 |
7 | modulation by symbiont of host defense response (GO:0052031) | 3.90270770 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.90270770 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.90270770 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.90270770 |
11 | modulation by symbiont of host immune response (GO:0052553) | 3.90270770 |
12 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.87002244 |
13 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.87002244 |
14 | positive regulation of mast cell activation (GO:0033005) | 3.85393947 |
15 | pinocytosis (GO:0006907) | 3.83468572 |
16 | ribosomal small subunit assembly (GO:0000028) | 3.83207389 |
17 | amino sugar catabolic process (GO:0046348) | 3.82595629 |
18 | heme biosynthetic process (GO:0006783) | 3.81088430 |
19 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.80077406 |
20 | barbed-end actin filament capping (GO:0051016) | 3.72272887 |
21 | positive regulation of mast cell degranulation (GO:0043306) | 3.71364860 |
22 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.71364860 |
23 | glycosphingolipid catabolic process (GO:0046479) | 3.67366232 |
24 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.65625359 |
25 | heme metabolic process (GO:0042168) | 3.65371752 |
26 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.64910560 |
27 | indole-containing compound catabolic process (GO:0042436) | 3.59751081 |
28 | indolalkylamine catabolic process (GO:0046218) | 3.59751081 |
29 | tryptophan catabolic process (GO:0006569) | 3.59751081 |
30 | regulation of leukocyte degranulation (GO:0043300) | 3.58221587 |
31 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.57893928 |
32 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.57066824 |
33 | aromatic amino acid family catabolic process (GO:0009074) | 3.45631445 |
34 | macrophage activation involved in immune response (GO:0002281) | 3.41893520 |
35 | regulation of superoxide anion generation (GO:0032928) | 3.39922667 |
36 | glyoxylate metabolic process (GO:0046487) | 3.37262531 |
37 | adenosine receptor signaling pathway (GO:0001973) | 3.35701268 |
38 | tryptophan metabolic process (GO:0006568) | 3.34547230 |
39 | aldehyde catabolic process (GO:0046185) | 3.29714468 |
40 | positive regulation of leukocyte degranulation (GO:0043302) | 3.29369015 |
41 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.26963260 |
42 | L-phenylalanine catabolic process (GO:0006559) | 3.26936680 |
43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.26936680 |
44 | L-phenylalanine metabolic process (GO:0006558) | 3.26801989 |
45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.26801989 |
46 | DNA deamination (GO:0045006) | 3.26519788 |
47 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.26467612 |
48 | detection of other organism (GO:0098543) | 3.25531871 |
49 | glycolipid catabolic process (GO:0019377) | 3.25360411 |
50 | granulocyte activation (GO:0036230) | 3.25087165 |
51 | B cell mediated immunity (GO:0019724) | 3.20390686 |
52 | regulation of mast cell activation (GO:0033003) | 3.18047400 |
53 | kynurenine metabolic process (GO:0070189) | 3.15093597 |
54 | detection of bacterium (GO:0016045) | 3.15035192 |
55 | killing of cells of other organism (GO:0031640) | 3.14095005 |
56 | disruption of cells of other organism (GO:0044364) | 3.14095005 |
57 | neutrophil activation involved in immune response (GO:0002283) | 3.13178249 |
58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.12973510 |
59 | cysteine metabolic process (GO:0006534) | 3.12070479 |
60 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.11182476 |
61 | reactive oxygen species biosynthetic process (GO:1903409) | 3.11060210 |
62 | myeloid cell activation involved in immune response (GO:0002275) | 3.08771918 |
63 | neutrophil activation (GO:0042119) | 3.08614322 |
64 | response to thyroid hormone (GO:0097066) | 3.07938384 |
65 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.06305137 |
66 | porphyrin-containing compound metabolic process (GO:0006778) | 3.04607471 |
67 | low-density lipoprotein particle remodeling (GO:0034374) | 3.02673538 |
68 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.99067679 |
69 | urea metabolic process (GO:0019627) | 2.94229662 |
70 | urea cycle (GO:0000050) | 2.94229662 |
71 | sulfur amino acid catabolic process (GO:0000098) | 2.94193441 |
72 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92756677 |
73 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.92605134 |
74 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.92441675 |
75 | NIK/NF-kappaB signaling (GO:0038061) | 2.90678931 |
76 | complement activation, alternative pathway (GO:0006957) | 2.90073736 |
77 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.87763047 |
78 | negative regulation of cell killing (GO:0031342) | 2.87763047 |
79 | response to muramyl dipeptide (GO:0032495) | 2.86423987 |
80 | glycine metabolic process (GO:0006544) | 2.86208488 |
81 | detection of external biotic stimulus (GO:0098581) | 2.86184001 |
82 | respiratory burst (GO:0045730) | 2.85351010 |
83 | oligosaccharide catabolic process (GO:0009313) | 2.84313966 |
84 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.83179931 |
85 | NAD biosynthetic process (GO:0009435) | 2.82294014 |
86 | N-acetylneuraminate metabolic process (GO:0006054) | 2.81458654 |
87 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.80709590 |
88 | regulation of growth of symbiont in host (GO:0044126) | 2.80709590 |
89 | negative regulation of growth of symbiont in host (GO:0044130) | 2.80709590 |
90 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.80709590 |
91 | bile acid biosynthetic process (GO:0006699) | 2.80103116 |
92 | ceramide catabolic process (GO:0046514) | 2.79591382 |
93 | serine family amino acid biosynthetic process (GO:0009070) | 2.79382996 |
94 | cellular response to arsenic-containing substance (GO:0071243) | 2.79309347 |
95 | positive regulation of antigen processing and presentation (GO:0002579) | 2.79270041 |
96 | regulation of mononuclear cell migration (GO:0071675) | 2.78349772 |
97 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.77760430 |
98 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.77713968 |
99 | amino-acid betaine metabolic process (GO:0006577) | 2.77707610 |
100 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.77270900 |
101 | protein carboxylation (GO:0018214) | 2.77270900 |
102 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.77151635 |
103 | response to host immune response (GO:0052572) | 2.77151635 |
104 | valine metabolic process (GO:0006573) | 2.76553530 |
105 | mature B cell differentiation involved in immune response (GO:0002313) | 2.75602545 |
106 | nitrogen cycle metabolic process (GO:0071941) | 2.75470708 |
107 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.74704970 |
108 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.74704970 |
109 | tetrapyrrole biosynthetic process (GO:0033014) | 2.74259214 |
110 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.74025184 |
111 | lysine catabolic process (GO:0006554) | 2.73985693 |
112 | lysine metabolic process (GO:0006553) | 2.73985693 |
113 | negative regulation of phagocytosis (GO:0050765) | 2.73297126 |
114 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.72701065 |
115 | phagosome maturation (GO:0090382) | 2.71430224 |
116 | detection of molecule of bacterial origin (GO:0032490) | 2.70836493 |
117 | regulation of platelet activation (GO:0010543) | 2.69776273 |
118 | urate metabolic process (GO:0046415) | 2.69217097 |
119 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.69087772 |
120 | regulation of regulated secretory pathway (GO:1903305) | 2.69043070 |
121 | modulation by symbiont of host cellular process (GO:0044068) | 2.68365895 |
122 | serine family amino acid metabolic process (GO:0009069) | 2.67238639 |
123 | macrophage differentiation (GO:0030225) | 2.65581134 |
124 | regulation of antigen processing and presentation (GO:0002577) | 2.65384117 |
125 | plasma lipoprotein particle remodeling (GO:0034369) | 2.63285187 |
126 | protein-lipid complex remodeling (GO:0034368) | 2.63285187 |
127 | macromolecular complex remodeling (GO:0034367) | 2.63285187 |
128 | cellular extravasation (GO:0045123) | 2.62622977 |
129 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.62053113 |
130 | pentose metabolic process (GO:0019321) | 2.61684911 |
131 | DNA strand elongation (GO:0022616) | 2.61642876 |
132 | protein localization to endosome (GO:0036010) | 2.60496299 |
133 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.60307152 |
134 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.60307152 |
135 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.60294300 |
136 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.60039220 |
137 | serine family amino acid catabolic process (GO:0009071) | 2.59926345 |
138 | myeloid dendritic cell differentiation (GO:0043011) | 2.59185744 |
139 | amine catabolic process (GO:0009310) | 2.59130374 |
140 | cellular biogenic amine catabolic process (GO:0042402) | 2.59130374 |
141 | regulation of protein activation cascade (GO:2000257) | 2.58553782 |
142 | modulation by virus of host process (GO:0019054) | 2.58246922 |
143 | alpha-linolenic acid metabolic process (GO:0036109) | 2.58214005 |
144 | macrophage activation (GO:0042116) | 2.58169732 |
145 | response to interferon-beta (GO:0035456) | 2.58162483 |
146 | myeloid dendritic cell activation (GO:0001773) | 2.58116243 |
147 | immunoglobulin mediated immune response (GO:0016064) | 2.55830242 |
148 | detection of biotic stimulus (GO:0009595) | 2.55443451 |
149 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.54793882 |
150 | T-helper 1 type immune response (GO:0042088) | 2.54734256 |
151 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.54638027 |
152 | phagocytosis, engulfment (GO:0006911) | 2.53793930 |
153 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.53320075 |
154 | imidazole-containing compound metabolic process (GO:0052803) | 2.52693901 |
155 | regulation of triglyceride catabolic process (GO:0010896) | 2.52690321 |
156 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.52653861 |
157 | cyclooxygenase pathway (GO:0019371) | 2.52477985 |
158 | high-density lipoprotein particle remodeling (GO:0034375) | 2.52227735 |
159 | regulation of cholesterol esterification (GO:0010872) | 2.51683723 |
160 | low-density lipoprotein particle clearance (GO:0034383) | 2.51287200 |
161 | negative regulation of granulocyte differentiation (GO:0030853) | 2.50970232 |
162 | telomere maintenance via recombination (GO:0000722) | 2.50926164 |
163 | response to host (GO:0075136) | 2.49911152 |
164 | response to host defenses (GO:0052200) | 2.49911152 |
165 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.49911152 |
166 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.49883085 |
167 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.49501842 |
168 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.49351724 |
169 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.49033892 |
170 | response to fungus (GO:0009620) | 2.48682565 |
171 | regulation of macrophage chemotaxis (GO:0010758) | 2.47929530 |
172 | aromatic amino acid family metabolic process (GO:0009072) | 2.47928094 |
173 | regulation of cholesterol storage (GO:0010885) | 2.47484927 |
174 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.46918280 |
175 | regulation of hypersensitivity (GO:0002883) | 2.46849799 |
176 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.46680138 |
177 | cofactor catabolic process (GO:0051187) | 2.46678319 |
178 | pyrimidine-containing compound salvage (GO:0008655) | 2.46507477 |
179 | pyrimidine nucleoside salvage (GO:0043097) | 2.46507477 |
180 | negative regulation of fibrinolysis (GO:0051918) | 2.45967516 |
181 | regulation of complement activation (GO:0030449) | 2.45855079 |
182 | drug transmembrane transport (GO:0006855) | 2.43250776 |
183 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.43187044 |
184 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.42837320 |
185 | drug transport (GO:0015893) | 2.42021621 |
186 | carnitine metabolic process (GO:0009437) | 2.41738489 |
187 | phospholipid efflux (GO:0033700) | 2.41285493 |
188 | indolalkylamine metabolic process (GO:0006586) | 2.41052908 |
189 | positive regulation of B cell differentiation (GO:0045579) | 2.40186903 |
190 | neutrophil mediated immunity (GO:0002446) | 2.39610234 |
191 | plasma lipoprotein particle assembly (GO:0034377) | 2.39031316 |
192 | cellular response to zinc ion (GO:0071294) | 2.38006780 |
193 | homocysteine metabolic process (GO:0050667) | 2.37767548 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.49120634 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.34318001 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.48591297 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.11083684 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.93484991 |
6 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.81125385 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.65958814 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.65480578 |
9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.62983077 |
10 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.61912766 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.35356994 |
12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.33597177 |
13 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.32954923 |
14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.25838299 |
15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.24559845 |
16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.24492799 |
17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.22468757 |
18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.21497783 |
19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.21473827 |
20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.18280763 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.17708317 |
22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.09290990 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.98625764 |
24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.97934642 |
25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.91743061 |
26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.91112934 |
27 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.86816322 |
28 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86654614 |
29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.86591400 |
30 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.86079646 |
31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.85627042 |
32 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.85374150 |
33 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.84747427 |
34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.84467009 |
35 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83199565 |
36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.82847915 |
37 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81877862 |
38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.80799582 |
39 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.80690375 |
40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76596774 |
41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.76478326 |
42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74076388 |
43 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.73495346 |
44 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70321975 |
45 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.67432124 |
46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.67295904 |
47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64130328 |
48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63437558 |
49 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61406597 |
50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57792028 |
51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56845743 |
52 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.56629409 |
53 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.54884367 |
54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54779026 |
55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.54149810 |
56 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.53986789 |
57 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.53740708 |
58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.52153493 |
59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.49307775 |
60 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48761582 |
61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.47731588 |
62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.47173980 |
63 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.46726369 |
64 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.46362730 |
65 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.45480935 |
66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.44962882 |
67 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.44854359 |
68 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43037441 |
69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42209392 |
70 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.40996537 |
71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.40167456 |
72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40139711 |
73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39759173 |
74 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.39039654 |
75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37969397 |
76 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37066026 |
77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36394971 |
78 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.36278081 |
79 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.35481343 |
80 | MAF_26560356_Chip-Seq_TH2_Human | 1.33980920 |
81 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.33896259 |
82 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.33659406 |
83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32440053 |
84 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.31417267 |
85 | P68_20966046_ChIP-Seq_HELA_Human | 1.27844660 |
86 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.27224489 |
87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26932196 |
88 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.26190336 |
89 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.24120795 |
90 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23743394 |
91 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22349762 |
92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.22219979 |
93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20922095 |
94 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20294892 |
95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20290753 |
96 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19991212 |
97 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.19926346 |
98 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18733758 |
99 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18166876 |
100 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17700154 |
101 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14519905 |
102 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.14510128 |
103 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14279893 |
104 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.14123073 |
105 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13669798 |
106 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.13660309 |
107 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13353873 |
108 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12457293 |
109 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11130385 |
110 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09974069 |
111 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.09832322 |
112 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09574665 |
113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09239942 |
114 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08651958 |
115 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07823942 |
116 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.07403373 |
117 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07303199 |
118 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06978107 |
119 | MYC_22102868_ChIP-Seq_BL_Human | 1.06920151 |
120 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06621208 |
121 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05699331 |
122 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.04811649 |
123 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04621832 |
124 | MAF_26560356_Chip-Seq_TH1_Human | 1.03884878 |
125 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.03492641 |
126 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.03195573 |
127 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02949730 |
128 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02858930 |
129 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02665567 |
130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01735655 |
131 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.01574449 |
132 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.01357189 |
133 | MYB_26560356_Chip-Seq_TH2_Human | 1.01157086 |
134 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00545443 |
135 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00059731 |
136 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.00056975 |
137 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99692498 |
138 | MYB_26560356_Chip-Seq_TH1_Human | 0.98190008 |
139 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98001741 |
140 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97660624 |
141 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97344144 |
142 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97138985 |
143 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96157579 |
144 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.96010883 |
145 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.94919961 |
146 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.93660276 |
147 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.91322154 |
148 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90990599 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.02048388 |
2 | MP0005360_urolithiasis | 3.97412650 |
3 | MP0003806_abnormal_nucleotide_metabolis | 3.04053113 |
4 | MP0005085_abnormal_gallbladder_physiolo | 2.98817408 |
5 | MP0003656_abnormal_erythrocyte_physiolo | 2.96924156 |
6 | MP0001835_abnormal_antigen_presentation | 2.91786404 |
7 | MP0005365_abnormal_bile_salt | 2.90618416 |
8 | MP0003436_decreased_susceptibility_to | 2.67441587 |
9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.51276592 |
10 | MP0009785_altered_susceptibility_to | 2.40549791 |
11 | * MP0003186_abnormal_redox_activity | 2.23233288 |
12 | MP0004147_increased_porphyrin_level | 2.22732924 |
13 | MP0004510_myositis | 2.17603899 |
14 | MP0002396_abnormal_hematopoietic_system | 2.16582876 |
15 | MP0003724_increased_susceptibility_to | 2.14264283 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.13968229 |
17 | MP0009840_abnormal_foam_cell | 2.11889901 |
18 | MP0002148_abnormal_hypersensitivity_rea | 2.05877449 |
19 | MP0003300_gastrointestinal_ulcer | 2.04707936 |
20 | MP0009278_abnormal_bone_marrow | 2.03913628 |
21 | MP0005025_abnormal_response_to | 2.00860816 |
22 | MP0002419_abnormal_innate_immunity | 1.99848118 |
23 | MP0001853_heart_inflammation | 1.88547628 |
24 | MP0008260_abnormal_autophagy | 1.86211026 |
25 | MP0005397_hematopoietic_system_phenotyp | 1.81686138 |
26 | MP0001545_abnormal_hematopoietic_system | 1.81686138 |
27 | * MP0003075_altered_response_to | 1.81167026 |
28 | MP0010329_abnormal_lipoprotein_level | 1.79445108 |
29 | MP0003828_pulmonary_edema | 1.78696254 |
30 | MP0000604_amyloidosis | 1.77194894 |
31 | MP0000685_abnormal_immune_system | 1.75408810 |
32 | MP0001764_abnormal_homeostasis | 1.73607151 |
33 | MP0005083_abnormal_biliary_tract | 1.71143305 |
34 | * MP0005464_abnormal_platelet_physiology | 1.70788653 |
35 | MP0005000_abnormal_immune_tolerance | 1.70155559 |
36 | MP0008004_abnormal_stomach_pH | 1.69223996 |
37 | MP0009764_decreased_sensitivity_to | 1.67990479 |
38 | MP0005332_abnormal_amino_acid | 1.66307936 |
39 | MP0003693_abnormal_embryo_hatching | 1.66091754 |
40 | MP0002998_abnormal_bone_remodeling | 1.65806587 |
41 | MP0003252_abnormal_bile_duct | 1.64364600 |
42 | MP0002138_abnormal_hepatobiliary_system | 1.58277480 |
43 | MP0008469_abnormal_protein_level | 1.58074951 |
44 | MP0000609_abnormal_liver_physiology | 1.50119850 |
45 | MP0008057_abnormal_DNA_replication | 1.50034116 |
46 | MP0005671_abnormal_response_to | 1.49253251 |
47 | MP0002452_abnormal_antigen_presenting | 1.48368264 |
48 | MP0001800_abnormal_humoral_immune | 1.46747407 |
49 | * MP0005319_abnormal_enzyme/_coenzyme | 1.46713074 |
50 | MP0004019_abnormal_vitamin_homeostasis | 1.45697682 |
51 | MP0002723_abnormal_immune_serum | 1.40996064 |
52 | * MP0001845_abnormal_inflammatory_respons | 1.37058923 |
53 | MP0002420_abnormal_adaptive_immunity | 1.34734043 |
54 | MP0001819_abnormal_immune_cell | 1.34715909 |
55 | MP0002166_altered_tumor_susceptibility | 1.34709819 |
56 | MP0003195_calcinosis | 1.33962888 |
57 | MP0010094_abnormal_chromosome_stability | 1.32965906 |
58 | MP0009643_abnormal_urine_homeostasis | 1.32060636 |
59 | MP0009333_abnormal_splenocyte_physiolog | 1.31909058 |
60 | MP0001666_abnormal_nutrient_absorption | 1.28623445 |
61 | MP0001790_abnormal_immune_system | 1.28272717 |
62 | MP0005387_immune_system_phenotype | 1.28272717 |
63 | MP0002398_abnormal_bone_marrow | 1.27989464 |
64 | MP0009763_increased_sensitivity_to | 1.27677642 |
65 | MP0000689_abnormal_spleen_morphology | 1.27509512 |
66 | MP0005166_decreased_susceptibility_to | 1.25166600 |
67 | MP0005058_abnormal_lysosome_morphology | 1.24408889 |
68 | MP0005636_abnormal_mineral_homeostasis | 1.24287977 |
69 | MP0005167_abnormal_blood-brain_barrier | 1.24060249 |
70 | MP0000858_altered_metastatic_potential | 1.23186398 |
71 | MP0003448_altered_tumor_morphology | 1.22334625 |
72 | MP0004782_abnormal_surfactant_physiolog | 1.21967115 |
73 | MP0002405_respiratory_system_inflammati | 1.21435364 |
74 | MP0002006_tumorigenesis | 1.20933098 |
75 | MP0003453_abnormal_keratinocyte_physiol | 1.20087188 |
76 | MP0003111_abnormal_nucleus_morphology | 1.20078905 |
77 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.19606195 |
78 | MP0002429_abnormal_blood_cell | 1.17758011 |
79 | MP0002722_abnormal_immune_system | 1.17072802 |
80 | MP0000716_abnormal_immune_system | 1.16388830 |
81 | MP0000343_altered_response_to | 1.16053232 |
82 | MP0000598_abnormal_liver_morphology | 1.16019774 |
83 | MP0002132_abnormal_respiratory_system | 1.15450927 |
84 | * MP0010155_abnormal_intestine_physiology | 1.12995679 |
85 | MP0001533_abnormal_skeleton_physiology | 1.12678704 |
86 | MP0006082_CNS_inflammation | 1.11797111 |
87 | * MP0000490_abnormal_crypts_of | 1.09598618 |
88 | * MP0006036_abnormal_mitochondrial_physio | 1.04054619 |
89 | MP0003303_peritoneal_inflammation | 1.03191907 |
90 | MP0001851_eye_inflammation | 1.02778181 |
91 | MP0001542_abnormal_bone_strength | 1.01835423 |
92 | MP0003183_abnormal_peptide_metabolism | 1.01831483 |
93 | MP0003690_abnormal_glial_cell | 1.00878113 |
94 | MP0009697_abnormal_copulation | 1.00625149 |
95 | MP0003279_aneurysm | 1.00594237 |
96 | MP0005390_skeleton_phenotype | 1.00558453 |
97 | MP0006054_spinal_hemorrhage | 1.00416439 |
98 | * MP0003077_abnormal_cell_cycle | 0.99712766 |
99 | MP0002877_abnormal_melanocyte_morpholog | 0.97834687 |
100 | * MP0002118_abnormal_lipid_homeostasis | 0.97462503 |
101 | MP0004957_abnormal_blastocyst_morpholog | 0.96570713 |
102 | MP0008007_abnormal_cellular_replicative | 0.95128633 |
103 | MP0000465_gastrointestinal_hemorrhage | 0.94414590 |
104 | MP0000249_abnormal_blood_vessel | 0.94193108 |
105 | MP0002019_abnormal_tumor_incidence | 0.93395160 |
106 | MP0008058_abnormal_DNA_repair | 0.92692711 |
107 | MP0005310_abnormal_salivary_gland | 0.92337927 |
108 | MP0001849_ear_inflammation | 0.91671879 |
109 | * MP0005165_increased_susceptibility_to | 0.91242197 |
110 | MP0005164_abnormal_response_to | 0.90426473 |
111 | MP0003566_abnormal_cell_adhesion | 0.89514828 |
112 | MP0003172_abnormal_lysosome_physiology | 0.89025968 |
113 | MP0002136_abnormal_kidney_physiology | 0.89012871 |
114 | MP0005075_abnormal_melanosome_morpholog | 0.89012711 |
115 | MP0005376_homeostasis/metabolism_phenot | 0.87544090 |
116 | MP0003329_amyloid_beta_deposits | 0.84654795 |
117 | MP0005666_abnormal_adipose_tissue | 0.83524980 |
118 | MP0009765_abnormal_xenobiotic_induced | 0.83359392 |
119 | MP0005023_abnormal_wound_healing | 0.83330260 |
120 | MP0004808_abnormal_hematopoietic_stem | 0.83265684 |
121 | MP0008873_increased_physiological_sensi | 0.83123412 |
122 | MP0003705_abnormal_hypodermis_morpholog | 0.81529726 |
123 | MP0004185_abnormal_adipocyte_glucose | 0.81213510 |
124 | MP0010307_abnormal_tumor_latency | 0.80915266 |
125 | MP0008874_decreased_physiological_sensi | 0.79469287 |
126 | MP0003795_abnormal_bone_structure | 0.79046670 |
127 | MP0005174_abnormal_tail_pigmentation | 0.78022256 |
128 | MP0005670_abnormal_white_adipose | 0.76860205 |
129 | MP0004883_abnormal_blood_vessel | 0.76754534 |
130 | MP0004947_skin_inflammation | 0.76674120 |
131 | MP0003763_abnormal_thymus_physiology | 0.76596768 |
132 | MP0009642_abnormal_blood_homeostasis | 0.73912960 |
133 | MP0005408_hypopigmentation | 0.73561622 |
134 | * MP0001663_abnormal_digestive_system | 0.72994288 |
135 | MP0003011_delayed_dark_adaptation | 0.72035287 |
136 | MP0005451_abnormal_body_composition | 0.71486047 |
137 | MP0003091_abnormal_cell_migration | 0.68106210 |
138 | MP0000015_abnormal_ear_pigmentation | 0.66192780 |
139 | MP0002933_joint_inflammation | 0.61852739 |
140 | MP0002332_abnormal_exercise_endurance | 0.60991430 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glycolipid metabolism (HP:0010969) | 6.02591532 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.02591532 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.02591532 |
4 | Increased cerebral lipofuscin (HP:0011813) | 4.63568145 |
5 | Dysostosis multiplex (HP:0000943) | 4.33197636 |
6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.02416696 |
7 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.01227037 |
8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.87178812 |
9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.70239181 |
10 | Recurrent abscess formation (HP:0002722) | 3.69717513 |
11 | Joint hemorrhage (HP:0005261) | 3.66709032 |
12 | Recurrent bacterial skin infections (HP:0005406) | 3.65340188 |
13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.51255733 |
14 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.49467420 |
15 | Loss of speech (HP:0002371) | 3.41859358 |
16 | Prolonged partial thromboplastin time (HP:0003645) | 3.40390212 |
17 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.38575521 |
18 | Thrombocytosis (HP:0001894) | 3.30317815 |
19 | Eczematoid dermatitis (HP:0000976) | 3.25339755 |
20 | Poikilocytosis (HP:0004447) | 3.22601806 |
21 | Intrahepatic cholestasis (HP:0001406) | 3.21955767 |
22 | Hepatosplenomegaly (HP:0001433) | 3.20835977 |
23 | Systemic lupus erythematosus (HP:0002725) | 3.17103104 |
24 | Amyloidosis (HP:0011034) | 3.09538411 |
25 | Hypobetalipoproteinemia (HP:0003563) | 3.07305210 |
26 | Petechiae (HP:0000967) | 3.05942198 |
27 | Abnormal number of erythroid precursors (HP:0012131) | 3.05530986 |
28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.02755185 |
29 | Nausea (HP:0002018) | 3.01973197 |
30 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.00551267 |
31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.00551267 |
32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.00551267 |
33 | Upper motor neuron abnormality (HP:0002127) | 3.00327317 |
34 | Deep venous thrombosis (HP:0002625) | 3.00286250 |
35 | Disinhibition (HP:0000734) | 2.93590986 |
36 | Xanthomatosis (HP:0000991) | 2.88941045 |
37 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.88636689 |
38 | Abnormal platelet volume (HP:0011876) | 2.81916851 |
39 | Reduced antithrombin III activity (HP:0001976) | 2.79922103 |
40 | Mucopolysacchariduria (HP:0008155) | 2.79652044 |
41 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.79652044 |
42 | Complement deficiency (HP:0004431) | 2.78643038 |
43 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.77665570 |
44 | Abnormality of the common coagulation pathway (HP:0010990) | 2.74469989 |
45 | Vertebral compression fractures (HP:0002953) | 2.72887136 |
46 | Hypochromic microcytic anemia (HP:0004840) | 2.72147819 |
47 | * Hyperbilirubinemia (HP:0002904) | 2.71480266 |
48 | Generalized aminoaciduria (HP:0002909) | 2.71224112 |
49 | Vacuolated lymphocytes (HP:0001922) | 2.70576200 |
50 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.66161424 |
51 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.66105475 |
52 | Mutism (HP:0002300) | 2.62063755 |
53 | Hyperammonemia (HP:0001987) | 2.60240066 |
54 | Autoimmune thrombocytopenia (HP:0001973) | 2.59270125 |
55 | Abnormality of complement system (HP:0005339) | 2.58927309 |
56 | Menorrhagia (HP:0000132) | 2.57574031 |
57 | Increased mean platelet volume (HP:0011877) | 2.56250126 |
58 | Myocardial infarction (HP:0001658) | 2.55316825 |
59 | Myositis (HP:0100614) | 2.54664792 |
60 | Acanthocytosis (HP:0001927) | 2.52635900 |
61 | Stomatitis (HP:0010280) | 2.51284171 |
62 | Epistaxis (HP:0000421) | 2.49338014 |
63 | Abnormality of macrophages (HP:0004311) | 2.48442340 |
64 | Cellulitis (HP:0100658) | 2.46186088 |
65 | Reticulocytopenia (HP:0001896) | 2.45130920 |
66 | Abnormality of nucleobase metabolism (HP:0010932) | 2.44068829 |
67 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.43138761 |
68 | Progressive neurologic deterioration (HP:0002344) | 2.41437087 |
69 | Urticaria (HP:0001025) | 2.40297273 |
70 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.35042030 |
71 | Increased serum ferritin (HP:0003281) | 2.33197228 |
72 | Microcytic anemia (HP:0001935) | 2.32798571 |
73 | Abnormality of iron homeostasis (HP:0011031) | 2.31964468 |
74 | Hyperlipoproteinemia (HP:0010980) | 2.31787360 |
75 | Hyperglycinuria (HP:0003108) | 2.31774186 |
76 | Recurrent skin infections (HP:0001581) | 2.30993455 |
77 | Gingival bleeding (HP:0000225) | 2.29088001 |
78 | Abnormality of methionine metabolism (HP:0010901) | 2.28379223 |
79 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.27751912 |
80 | Prolonged neonatal jaundice (HP:0006579) | 2.27505602 |
81 | Hypoglycemic coma (HP:0001325) | 2.26321746 |
82 | Hepatocellular carcinoma (HP:0001402) | 2.25857932 |
83 | IgM deficiency (HP:0002850) | 2.25710283 |
84 | Aplastic anemia (HP:0001915) | 2.24787068 |
85 | Nuclear cataract (HP:0100018) | 2.24205247 |
86 | Abnormality of the prostate (HP:0008775) | 2.23760541 |
87 | Hypochromic anemia (HP:0001931) | 2.21850553 |
88 | Meningitis (HP:0001287) | 2.21555809 |
89 | Abnormality of reticulocytes (HP:0004312) | 2.20981200 |
90 | Fat malabsorption (HP:0002630) | 2.19249833 |
91 | Dicarboxylic aciduria (HP:0003215) | 2.18121544 |
92 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.18121544 |
93 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.17940283 |
94 | Thrombophlebitis (HP:0004418) | 2.17800169 |
95 | Periodontitis (HP:0000704) | 2.17248516 |
96 | Recurrent fungal infections (HP:0002841) | 2.16468404 |
97 | Abnormality of the intrinsic pathway (HP:0010989) | 2.14435268 |
98 | Hypertensive crisis (HP:0100735) | 2.14245629 |
99 | Mediastinal lymphadenopathy (HP:0100721) | 2.13750803 |
100 | Glomerulonephritis (HP:0000099) | 2.12939698 |
101 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.10946851 |
102 | Neurofibrillary tangles (HP:0002185) | 2.10515359 |
103 | Pustule (HP:0200039) | 2.09942283 |
104 | Polygenic inheritance (HP:0010982) | 2.09704105 |
105 | Purpura (HP:0000979) | 2.09267314 |
106 | Conjunctival telangiectasia (HP:0000524) | 2.08814184 |
107 | Reticulocytosis (HP:0001923) | 2.07396983 |
108 | Proximal tubulopathy (HP:0000114) | 2.07013685 |
109 | Thoracic kyphosis (HP:0002942) | 2.06418149 |
110 | Neuronal loss in central nervous system (HP:0002529) | 2.06167925 |
111 | Increased IgM level (HP:0003496) | 2.03164008 |
112 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03041801 |
113 | Obstructive lung disease (HP:0006536) | 2.03041801 |
114 | Abnormality of T cell physiology (HP:0011840) | 2.02572086 |
115 | Hypolipoproteinemia (HP:0010981) | 1.99885027 |
116 | Abnormality of glycine metabolism (HP:0010895) | 1.99823053 |
117 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.99823053 |
118 | Pathologic fracture (HP:0002756) | 1.99234777 |
119 | Hypertriglyceridemia (HP:0002155) | 1.98236015 |
120 | Steatorrhea (HP:0002570) | 1.98203970 |
121 | Cholelithiasis (HP:0001081) | 1.96889116 |
122 | Spontaneous hematomas (HP:0007420) | 1.96577285 |
123 | Impaired platelet aggregation (HP:0003540) | 1.96391630 |
124 | Abnormal platelet function (HP:0011869) | 1.96391630 |
125 | Hepatic necrosis (HP:0002605) | 1.96165447 |
126 | Nonimmune hydrops fetalis (HP:0001790) | 1.95871893 |
127 | Abnormality of the nasal mucosa (HP:0000433) | 1.95582272 |
128 | Orchitis (HP:0100796) | 1.95333192 |
129 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.93603652 |
130 | Recurrent viral infections (HP:0004429) | 1.93521555 |
131 | Prolonged bleeding time (HP:0003010) | 1.92546254 |
132 | Delayed CNS myelination (HP:0002188) | 1.91746031 |
133 | Personality changes (HP:0000751) | 1.91552161 |
134 | Abnormality of purine metabolism (HP:0004352) | 1.91369533 |
135 | Diminished motivation (HP:0000745) | 1.91103259 |
136 | Axonal loss (HP:0003447) | 1.89051350 |
137 | Distal lower limb muscle weakness (HP:0009053) | 1.88746479 |
138 | Type I transferrin isoform profile (HP:0003642) | 1.88510105 |
139 | Basal ganglia calcification (HP:0002135) | 1.87926342 |
140 | Colitis (HP:0002583) | 1.87848375 |
141 | Gastrointestinal inflammation (HP:0004386) | 1.87187960 |
142 | Inflammation of the large intestine (HP:0002037) | 1.86475424 |
143 | Hypercholesterolemia (HP:0003124) | 1.86384933 |
144 | Ketosis (HP:0001946) | 1.85733238 |
145 | Macrocytic anemia (HP:0001972) | 1.84759947 |
146 | Glycosuria (HP:0003076) | 1.84564433 |
147 | Abnormality of urine glucose concentration (HP:0011016) | 1.84564433 |
148 | Poor head control (HP:0002421) | 1.84435413 |
149 | Gingivitis (HP:0000230) | 1.83676266 |
150 | Hyperglycinemia (HP:0002154) | 1.83631284 |
151 | Polycythemia (HP:0001901) | 1.82762774 |
152 | Bone pain (HP:0002653) | 1.81778842 |
153 | Increased IgE level (HP:0003212) | 1.80940589 |
154 | Vasculitis (HP:0002633) | 1.80901740 |
155 | Dementia (HP:0000726) | 1.80344989 |
156 | Apathy (HP:0000741) | 1.79251614 |
157 | Cerebral inclusion bodies (HP:0100314) | 1.77461823 |
158 | Recurrent cutaneous fungal infections (HP:0011370) | 1.77019408 |
159 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.77019408 |
160 | Retrobulbar optic neuritis (HP:0100654) | 1.74711343 |
161 | Optic neuritis (HP:0100653) | 1.74711343 |
162 | Pulmonary infiltrates (HP:0002113) | 1.73662680 |
163 | Abnormality of lateral ventricle (HP:0030047) | 1.73364933 |
164 | Achilles tendon contracture (HP:0001771) | 1.72729039 |
165 | Asymmetric septal hypertrophy (HP:0001670) | 1.71827357 |
166 | Abnormality of the Achilles tendon (HP:0005109) | 1.71530640 |
167 | Agnosia (HP:0010524) | 1.68728146 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EIF2AK1 | 3.05599394 |
2 | NME2 | 2.87221298 |
3 | PIM2 | 2.83830542 |
4 | IRAK4 | 2.63133560 |
5 | BLK | 2.48437852 |
6 | BCKDK | 2.48276384 |
7 | MAP3K14 | 2.43189034 |
8 | ARAF | 2.42195618 |
9 | STK16 | 2.39539117 |
10 | IRAK3 | 2.37516173 |
11 | ERN1 | 2.33473006 |
12 | PRPF4B | 2.07020073 |
13 | TAOK3 | 2.05079209 |
14 | MAP4K1 | 2.04085750 |
15 | MAP2K3 | 1.99985207 |
16 | TYK2 | 1.94171950 |
17 | KIT | 1.84116033 |
18 | FLT3 | 1.83128192 |
19 | TBK1 | 1.82567773 |
20 | TEC | 1.79352667 |
21 | WEE1 | 1.78082671 |
22 | BUB1 | 1.77955933 |
23 | FES | 1.76714768 |
24 | BTK | 1.73998361 |
25 | EIF2AK3 | 1.64611790 |
26 | PIM1 | 1.59030942 |
27 | PBK | 1.54019642 |
28 | IKBKB | 1.49574786 |
29 | VRK1 | 1.47626644 |
30 | FGR | 1.43208531 |
31 | STK4 | 1.40010869 |
32 | TAOK1 | 1.38771108 |
33 | MAP3K11 | 1.35634443 |
34 | KDR | 1.33815957 |
35 | BRSK2 | 1.33630166 |
36 | NEK9 | 1.32995440 |
37 | IKBKE | 1.32060732 |
38 | SMG1 | 1.29206634 |
39 | GRK7 | 1.27496606 |
40 | ACVR1B | 1.23436702 |
41 | VRK2 | 1.23161670 |
42 | JAK3 | 1.22210217 |
43 | BMX | 1.19305573 |
44 | CDC7 | 1.17820594 |
45 | RPS6KA4 | 1.17374621 |
46 | MOS | 1.17187543 |
47 | ZAP70 | 1.15421143 |
48 | ZAK | 1.15097601 |
49 | STK10 | 1.15062515 |
50 | TLK1 | 1.09560299 |
51 | SYK | 1.08943886 |
52 | CSF1R | 1.05305660 |
53 | MAP3K1 | 1.04130344 |
54 | DDR2 | 1.01228107 |
55 | LIMK1 | 1.00855212 |
56 | PIK3CG | 1.00782166 |
57 | HCK | 1.00689000 |
58 | SCYL2 | 1.00477909 |
59 | TNK2 | 1.00417962 |
60 | TRIB3 | 0.98744411 |
61 | EIF2AK2 | 0.97570875 |
62 | LRRK2 | 0.95437003 |
63 | BRAF | 0.95375635 |
64 | LYN | 0.94595239 |
65 | MAP3K13 | 0.93438709 |
66 | EPHB2 | 0.93361710 |
67 | TXK | 0.92609216 |
68 | MAP3K12 | 0.91875119 |
69 | DYRK3 | 0.91167169 |
70 | MAP3K3 | 0.89991660 |
71 | DAPK3 | 0.89396129 |
72 | TRPM7 | 0.87406128 |
73 | CDK7 | 0.85938952 |
74 | NEK1 | 0.85436258 |
75 | MAPK11 | 0.84858255 |
76 | MST1R | 0.84463533 |
77 | TGFBR2 | 0.84330030 |
78 | GRK6 | 0.83878556 |
79 | TESK2 | 0.83407175 |
80 | JAK2 | 0.82196972 |
81 | MAP3K8 | 0.82108218 |
82 | PKN2 | 0.81845056 |
83 | MATK | 0.81000517 |
84 | CDK19 | 0.80856322 |
85 | NEK2 | 0.80222324 |
86 | PAK4 | 0.79790391 |
87 | PDPK1 | 0.79004311 |
88 | CDK4 | 0.77690036 |
89 | ATR | 0.77641121 |
90 | CDC42BPA | 0.76195598 |
91 | CLK1 | 0.75363116 |
92 | * ABL2 | 0.74188896 |
93 | TGFBR1 | 0.74036454 |
94 | MAPKAPK3 | 0.72513457 |
95 | RPS6KA6 | 0.72304796 |
96 | AURKB | 0.71542681 |
97 | ILK | 0.70743889 |
98 | CDK6 | 0.69457443 |
99 | BRSK1 | 0.68860640 |
100 | CHUK | 0.68195811 |
101 | PRKD2 | 0.67943194 |
102 | CAMKK2 | 0.66008855 |
103 | PAK1 | 0.65548507 |
104 | RPS6KB2 | 0.65127654 |
105 | MYLK | 0.64573597 |
106 | RIPK4 | 0.63675084 |
107 | RPS6KL1 | 0.63116834 |
108 | RPS6KC1 | 0.63116834 |
109 | TAOK2 | 0.58977470 |
110 | PLK4 | 0.58700814 |
111 | SRPK1 | 0.58114740 |
112 | TESK1 | 0.57040625 |
113 | JAK1 | 0.56832151 |
114 | RPS6KA2 | 0.56282944 |
115 | MAPK12 | 0.55809656 |
116 | PLK1 | 0.55679639 |
117 | FGFR4 | 0.54221386 |
118 | IRAK2 | 0.53547289 |
119 | MST4 | 0.52992229 |
120 | DAPK1 | 0.52986343 |
121 | MARK3 | 0.52441896 |
122 | MAPK4 | 0.51831594 |
123 | SIK1 | 0.50166764 |
124 | TTN | 0.49636579 |
125 | CSK | 0.49259433 |
126 | PRKG2 | 0.48670778 |
127 | LCK | 0.48599473 |
128 | PDK1 | 0.48523753 |
129 | GRK5 | 0.48468805 |
130 | RIPK1 | 0.47983124 |
131 | PRKCD | 0.47278813 |
132 | EPHB1 | 0.47158086 |
133 | CSNK2A1 | 0.45683698 |
134 | MAP3K5 | 0.45095278 |
135 | ICK | 0.44465586 |
136 | MAP2K6 | 0.44350913 |
137 | SIK3 | 0.44291632 |
138 | BMPR2 | 0.43227973 |
139 | CAMK1D | 0.42659655 |
140 | TIE1 | 0.41847934 |
141 | HIPK2 | 0.40955993 |
142 | TTK | 0.40687636 |
143 | MAP3K6 | 0.38774221 |
144 | PTK2B | 0.34866062 |
145 | MARK2 | 0.34419981 |
146 | MAPKAPK2 | 0.33266634 |
147 | LMTK2 | 0.30263770 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.68396376 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.67802874 |
3 | DNA replication_Homo sapiens_hsa03030 | 2.61223496 |
4 | Asthma_Homo sapiens_hsa05310 | 2.52535747 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.50593410 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.49754327 |
7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24167055 |
8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.23174414 |
9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.12406112 |
10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.06159132 |
11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.05503948 |
12 | Tuberculosis_Homo sapiens_hsa05152 | 2.05093270 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.93793435 |
14 | Phagosome_Homo sapiens_hsa04145 | 1.92431154 |
15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.91634545 |
16 | Ribosome_Homo sapiens_hsa03010 | 1.88456243 |
17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.85793355 |
18 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.75778638 |
19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.75454897 |
20 | Proteasome_Homo sapiens_hsa03050 | 1.71475339 |
21 | Peroxisome_Homo sapiens_hsa04146 | 1.71434256 |
22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.70203744 |
23 | Mismatch repair_Homo sapiens_hsa03430 | 1.69732472 |
24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.69600281 |
25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.62769326 |
26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.55825324 |
27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.55136395 |
28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54811675 |
29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51853712 |
30 | Salmonella infection_Homo sapiens_hsa05132 | 1.51734180 |
31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51256427 |
32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.50651555 |
33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.49529767 |
34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.48977572 |
35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.45342236 |
36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.44332647 |
37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44329241 |
38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.43329740 |
39 | Base excision repair_Homo sapiens_hsa03410 | 1.42443619 |
40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.42331086 |
41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.40254276 |
42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39153621 |
43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39113080 |
44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36060326 |
45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.35319127 |
46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.35034052 |
47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.32593190 |
48 | Shigellosis_Homo sapiens_hsa05131 | 1.32134766 |
49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.29748297 |
50 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.28068235 |
51 | Platelet activation_Homo sapiens_hsa04611 | 1.25808213 |
52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.24607353 |
53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22576985 |
54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.21387166 |
55 | Homologous recombination_Homo sapiens_hsa03440 | 1.20723871 |
56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20267737 |
57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.19939086 |
58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19785457 |
59 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16726471 |
60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.16093915 |
61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15956318 |
62 | Leishmaniasis_Homo sapiens_hsa05140 | 1.15136550 |
63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.13419403 |
64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.09813889 |
65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09235308 |
66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07971449 |
67 | * Glutathione metabolism_Homo sapiens_hsa00480 | 1.07010903 |
68 | Legionellosis_Homo sapiens_hsa05134 | 1.06357282 |
69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04659727 |
70 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04369670 |
71 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.03812762 |
72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02809221 |
73 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.01230974 |
74 | Retinol metabolism_Homo sapiens_hsa00830 | 1.01229030 |
75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00711909 |
76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00583528 |
77 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00439945 |
78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99778582 |
79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98889403 |
80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97581289 |
81 | Prion diseases_Homo sapiens_hsa05020 | 0.96763858 |
82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.95848186 |
83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95129697 |
84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94795345 |
85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.93721900 |
86 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93605782 |
87 | Bladder cancer_Homo sapiens_hsa05219 | 0.92266492 |
88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.90839679 |
89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88635892 |
90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86248121 |
91 | RNA polymerase_Homo sapiens_hsa03020 | 0.85293693 |
92 | ABC transporters_Homo sapiens_hsa02010 | 0.82612799 |
93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80665400 |
94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79641476 |
95 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78782273 |
96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78364612 |
97 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.77416506 |
98 | Pertussis_Homo sapiens_hsa05133 | 0.76712160 |
99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75702044 |
100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75417732 |
101 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75163924 |
102 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.74724892 |
103 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74476191 |
104 | Amoebiasis_Homo sapiens_hsa05146 | 0.73437747 |
105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72853569 |
106 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72688219 |
107 | Endocytosis_Homo sapiens_hsa04144 | 0.72329910 |
108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71238405 |
109 | Protein export_Homo sapiens_hsa03060 | 0.71057668 |
110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70941168 |
111 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.70892723 |
112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69778913 |
113 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.69637807 |
114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69359121 |
115 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.68504939 |
116 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68121108 |
117 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65907392 |
118 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65320246 |
119 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64867951 |
120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64012047 |
121 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63471682 |
122 | Measles_Homo sapiens_hsa05162 | 0.61273376 |
123 | Malaria_Homo sapiens_hsa05144 | 0.60930869 |
124 | Hepatitis C_Homo sapiens_hsa05160 | 0.58387333 |
125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56249872 |
126 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56231256 |
127 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55921843 |
128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55500773 |
129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55103325 |
130 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55055746 |
131 | Hepatitis B_Homo sapiens_hsa05161 | 0.54702194 |
132 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54659463 |
133 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54101045 |
134 | Spliceosome_Homo sapiens_hsa03040 | 0.53726884 |
135 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52225640 |
136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52033570 |
137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50255391 |
138 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49991807 |
139 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49488110 |
140 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.48846552 |
141 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48818158 |
142 | Lysosome_Homo sapiens_hsa04142 | 0.47758088 |
143 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.47258608 |
144 | Allograft rejection_Homo sapiens_hsa05330 | 0.46502341 |
145 | Cell cycle_Homo sapiens_hsa04110 | 0.45873604 |
146 | Apoptosis_Homo sapiens_hsa04210 | 0.45605175 |
147 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.45155555 |
148 | Influenza A_Homo sapiens_hsa05164 | 0.45149918 |
149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44816932 |
150 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43925962 |
151 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43373794 |
152 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42753342 |
153 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.42573788 |
154 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40468043 |
155 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37887048 |
156 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37167062 |
157 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.35112519 |
158 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.34318219 |
159 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32879370 |
160 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31874653 |
161 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28905380 |